Yvette I. Sheline
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yvette I. Sheline has a total of 335 co-authors. Here are the top co-authors by number of shared publications:
- Desmond J. Oathes
Center for Neuromodulation in Depression and Stress Department of Psychiatry University of Pennsylvania Philadelphia, Philadelphia, USA
7 shared publications Kevin G. Lynch
Department of Psychiatry University of Pennsylvania Philadelphia, Philadelphia, USA
7 shared publicationsWalid Makhoul
Center for Neuromodulation in Depression and Stress Department of Psychiatry University of Pennsylvania Philadelphia, Philadelphia, USA
7 shared publicationsDarsol Seok
Center for Neuromodulation in Depression and Stress, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
6 shared publicationsDesmond J. Oathes
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States
6 shared publications- Nicholas L. Balderston
Center for Neuromodulation in Depression and Stress Department of Psychiatry University of Pennsylvania Philadelphia, Philadelphia, USA
6 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Springer Nature in Communications Biology
iTBS and cTBS to an individualized dlPFC target produce differential working memory improvement and session-dependent putamen deactivation
- 2 November 2026
- Published by Springer Nature in Communications Biology
Open AccessiTBS and cTBS to an individualized dlPFC target produce differential working memory improvement and session-dependent putamen deactivation
- Open Access
Escaping the Negative Attentional Bias in Depression with Real-Time Neurofeedback
Individuals with major depressive disorder (MDD) show an attentional bias toward negatively valenced stimuli and thoughts. In this study, we applied a closed-loop neurofeedback procedure designed to reduce this bias. Participants were shown composite negative faces and neutral scenes with variable opacity and were instructed to attend to the neutral scene while ignoring the negative face. Internal attentional states were decoded in real time from functional magnetic resonance imaging (fMRI) data. When a participant’s decoded attentional state indicated a failure to ignore the negative faces, the faces became more visible (higher opacity), thus externalizing the brain’s attentional lapse in that moment. Forty-eight individuals with MDD were randomly assigned to a real neurofeedback training group (N = 24) or a sham control group (N = 24); the control group received feedback yoked to a participant in the real group. All participants completed three fMRI neurofeedback sessions. The main outcome quantified the extent to which participants got “stuck” in the most negative attentional state of focusing strongly on the negative faces. We hypothesized that the real neurofeedback group would learn to escape that state by the end of training, relative to the sham control group. Consistent with our hypothesis, neurofeedback training reduced the probability of getting stuck in the most negative attentional state. In offline analyses, training reduced fMRI activity in the precuneus/posterior cingulate and the medial prefrontal cortex when participants successfully attended to scenes and ignored faces. These results demonstrate the efficacy of remediating the negative attentional bias in depression with closed-loop neurofeedback from real-time fMRI.
Open AccessEscaping the Negative Attentional Bias in Depression with Real-Time Neurofeedback
Individuals with major depressive disorder (MDD) show an attentional bias toward negatively valenced stimuli and thoughts. In this study, we applied a closed-loop neurofeedback procedure designed to reduce this bias. Participants were shown composite negative faces and neutral scenes with variable opacity and were instructed to attend to the neutral scene while ignoring the negative face. Internal attentional states were decoded in real time from functional magnetic resonance imaging (fMRI) data. When a participant’s decoded attentional state indicated a failure to ignore the negative faces, the faces became more visible (higher opacity), thus externalizing the brain’s attentional lapse in that moment. Forty-eight individuals with MDD were randomly assigned to a real neurofeedback training group (N = 24) or a sham control group (N = 24); the control group received feedback yoked to a participant in the real group. All participants completed three fMRI neurofeedback sessions. The main outcome quantified the extent to which participants got “stuck” in the most negative attentional state of focusing strongly on the negative faces. We hypothesized that the real neurofeedback group would learn to escape that state by the end of training, relative to the sham control group. Consistent with our hypothesis, neurofeedback training reduced the probability of getting stuck in the most negative attentional state. In offline analyses, training reduced fMRI activity in the precuneus/posterior cingulate and the medial prefrontal cortex when participants successfully attended to scenes and ignored faces. These results demonstrate the efficacy of remediating the negative attentional bias in depression with closed-loop neurofeedback from real-time fMRI.
- Open Access
- 8 September 2026
- Published by Springer Nature in Research Square
Electroconvulsive therapy modulates neurite density and free water in discrete white matter compartments in major depression
Electroconvulsive therapy (ECT) is the most effective treatment for severe or intractable depression. The disrupt–potentiate–rewire framework proposes that ECT’s therapeutic effects include neural remodeling. We used the neurite orientation dispersion and density imaging (NODDI) model to characterize ECT-related longitudinal white matter (WM) microstructural changes. Fifty-two adults with treatment-resistant major depressive episodes (32 female) from two cohorts underwent multi-shell diffusion MRI and clinical assessment before the first ECT session and after completion of the index course. Plasma interleukin-6 (IL-6) was measured in one cohort. Linear mixed-effects models assessed longitudinal changes in neurite density, orientation dispersion, and free water across major WM tracts, with false-discovery-rate correction. Regression analyses examined relationships between WM changes, symptom improvement, and IL-6 change if available. Fractional anisotropy (FA) was also examined for comparison with prior studies. Depressive symptoms improved substantially, and IL-6 levels decreased following treatment. Neurite density, free water, and FA decreased across multiple frontolimbic pathways, including the uncinate fasciculus, external capsule, and internal capsule, whereas orientation dispersion remained unchanged. Free-water reductions were predominantly right-lateralized. In contrast to FA, greater NODDI-derived microstructural change was associated with greater depression symptom improvement across several mood-relevant pathways, while reductions in IL-6 showed trend-level associations with WM change. ECT was associated with coordinated reductions in neurite density and free water, alongside preserved fiber organization, within distributed WM pathways. These findings support microstructural remodeling during the putative rewiring phase of ECT and link WM change to both antidepressant improvement and changes in peripheral inflammation.
- 8 September 2026
- Published by Springer Nature in Research Square
Open AccessElectroconvulsive therapy modulates neurite density and free water in discrete white matter compartments in major depression
Electroconvulsive therapy (ECT) is the most effective treatment for severe or intractable depression. The disrupt–potentiate–rewire framework proposes that ECT’s therapeutic effects include neural remodeling. We used the neurite orientation dispersion and density imaging (NODDI) model to characterize ECT-related longitudinal white matter (WM) microstructural changes. Fifty-two adults with treatment-resistant major depressive episodes (32 female) from two cohorts underwent multi-shell diffusion MRI and clinical assessment before the first ECT session and after completion of the index course. Plasma interleukin-6 (IL-6) was measured in one cohort. Linear mixed-effects models assessed longitudinal changes in neurite density, orientation dispersion, and free water across major WM tracts, with false-discovery-rate correction. Regression analyses examined relationships between WM changes, symptom improvement, and IL-6 change if available. Fractional anisotropy (FA) was also examined for comparison with prior studies. Depressive symptoms improved substantially, and IL-6 levels decreased following treatment. Neurite density, free water, and FA decreased across multiple frontolimbic pathways, including the uncinate fasciculus, external capsule, and internal capsule, whereas orientation dispersion remained unchanged. Free-water reductions were predominantly right-lateralized. In contrast to FA, greater NODDI-derived microstructural change was associated with greater depression symptom improvement across several mood-relevant pathways, while reductions in IL-6 showed trend-level associations with WM change. ECT was associated with coordinated reductions in neurite density and free water, alongside preserved fiber organization, within distributed WM pathways. These findings support microstructural remodeling during the putative rewiring phase of ECT and link WM change to both antidepressant improvement and changes in peripheral inflammation.
- Open Access
- 13 July 2026
- Published by Springer Nature in Nature Mental Health
The neuroimaging correlates of depression established across six large-scale population datasets
- 13 July 2026
- Published by Springer Nature in Nature Mental Health
Open AccessThe neuroimaging correlates of depression established across six large-scale population datasets
- Open Access
- 29 January 2026
- Published by Elsevier in Transcranial Magnetic Stimulation
- Vol. 6
Decreased within-default mode network connectivity with accelerated intermittent theta burst stimulation across unipolar and bipolar depression: Candidate transdiagnostic circuit marker for treatment response
- 29 January 2026
- Published by Elsevier in Transcranial Magnetic Stimulation
- Vol. 6
Open AccessDecreased within-default mode network connectivity with accelerated intermittent theta burst stimulation across unipolar and bipolar depression: Candidate transdiagnostic circuit marker for treatment response
- Open Access
Decreased within-default mode network connectivity with accelerated intermittent theta burst stimulation across unipolar and bipolar depression: Candidate transdiagnostic circuit marker for treatment response
Background: An accelerated schedule of intermittent theta burst stimulation (aiTBS) has been shown to improve clinical efficacy of transcranial magnetic stimulation for bipolar disorder (BD) and major depressive disorder (MDD). We investigated the functional connectivity changes underpinning clinical effects of aiTBS on transdiagnostic treatment-resistant depression (TRD). Methods: Data were collected from two studies: an open-label active aiTBS study for MDD and a double-blind, randomized control aiTBS study for BD. Thirty-four participants (18 female/16 male) with transdiagnostic TRD currently experiencing moderate to severe depressive episodes (Montgomery-Åsberg Rating Scale [MADRS] score ≥ 20). Participants received active (22 total; 12 BD/10MDD) or sham (12 BD) aiTBS delivered to personalized left dorsolateral prefrontal cortical targets. Participants completed MRI scans before and after ten sessions of active or sham aiTBS per day for five days. Within each aiTBS group (active/sham), connectivity changes within the default mode network (DMN) following aiTBS and their correlations with MADRS scores were evaluated. Results: Immediately following aiTBS, active group members had lower within-DMN connectivity ( p = .01, d = –0.62) and lower MADRS scores ( p < .0001) than at baseline; these changes were correlated ( r = .47, p = .03). They also reported decreased insomnia ( p < .0001) and suicidality ( p < .0001). These changes were not present in the sham BD group ( p s = .29– .92). Conclusions: aiTBS was associated with decreased within-DMN connectivity among people with transdiagnostic TRD, which could underlie depression improvement. The study is registered on ClinicalTrials.gov (study identifier NCT05228457 ). https://clinicaltrials.gov/study/NCT05228457
Open AccessDecreased within-default mode network connectivity with accelerated intermittent theta burst stimulation across unipolar and bipolar depression: Candidate transdiagnostic circuit marker for treatment response
Background: An accelerated schedule of intermittent theta burst stimulation (aiTBS) has been shown to improve clinical efficacy of transcranial magnetic stimulation for bipolar disorder (BD) and major depressive disorder (MDD). We investigated the functional connectivity changes underpinning clinical effects of aiTBS on transdiagnostic treatment-resistant depression (TRD). Methods: Data were collected from two studies: an open-label active aiTBS study for MDD and a double-blind, randomized control aiTBS study for BD. Thirty-four participants (18 female/16 male) with transdiagnostic TRD currently experiencing moderate to severe depressive episodes (Montgomery-Åsberg Rating Scale [MADRS] score ≥ 20). Participants received active (22 total; 12 BD/10MDD) or sham (12 BD) aiTBS delivered to personalized left dorsolateral prefrontal cortical targets. Participants completed MRI scans before and after ten sessions of active or sham aiTBS per day for five days. Within each aiTBS group (active/sham), connectivity changes within the default mode network (DMN) following aiTBS and their correlations with MADRS scores were evaluated. Results: Immediately following aiTBS, active group members had lower within-DMN connectivity ( p = .01, d = –0.62) and lower MADRS scores ( p < .0001) than at baseline; these changes were correlated ( r = .47, p = .03). They also reported decreased insomnia ( p < .0001) and suicidality ( p < .0001). These changes were not present in the sham BD group ( p s = .29– .92). Conclusions: aiTBS was associated with decreased within-DMN connectivity among people with transdiagnostic TRD, which could underlie depression improvement. The study is registered on ClinicalTrials.gov (study identifier NCT05228457 ). https://clinicaltrials.gov/study/NCT05228457
- Open Access
- 23 December 2025
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 49, 101591
A mechanistic trial of the neurobiology of extinction learning and intraparietal sulcus stimulation: Protocol
- 23 December 2025
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 49, 101591
Open AccessA mechanistic trial of the neurobiology of extinction learning and intraparietal sulcus stimulation: Protocol
- 12 December 2025
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (1) , 85-101
Generalizable structure–function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion
Major depressive disorder (MDD) is a prevalent condition that profoundly impairs quality of life across diverse populations. Despite widespread use, current antidepressant and psychotherapeutic treatments exhibit limited efficacy and unsatisfactory response rates. Progress in developing effective therapies is hampered by the insufficiently understood heterogeneity of MDD and its elusive underlying mechanisms. Here, to address these challenges, we develop a novel machine learning framework that identifies structure–function covariation through target-oriented fusion of structural and functional connectivity, which robustly predicts individual-level antidepressant response (sertraline, R2 = 0.31; placebo, R2 = 0.22). Validation in an independent escitalopram-medicated MDD cohort confirms the biomarker’s generalizability (P = 0.01) and suggests an overlap of psychopharmacological signatures across selective serotonin reuptake inhibitors. Our models highlight the right precuneus as a common key region for both sertraline and placebo responses, with the right middle frontal gyrus and left fusiform gyrus specific to sertraline and the left inferior and middle frontal gyri to placebo. We also find that structural connectivity is more predictive of sertraline response, while functional connectivity better predicts placebo response. The framework further decomposes the overall predictive patterns into three constitutive network constellations (default-mode regulatory, affective and sensory processing), which exhibit distinct generalizable structure–function covariation and treatment-specific association with personality traits and behavioral/cognitive profiles. These findings provide unique insights to the structure–function covariation in patients with MDD, its association to the heterogeneity in antidepressant response and the dissection of the intricate MDD neuropsychopharmacology, paving the way for precision medicine and development of more targeted antidepressant therapeutics. Clinicaltrials.gov registration: Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression (EMBARC), NCT01407094.
- 12 December 2025
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (1) , 85-101
Generalizable structure–function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion
Major depressive disorder (MDD) is a prevalent condition that profoundly impairs quality of life across diverse populations. Despite widespread use, current antidepressant and psychotherapeutic treatments exhibit limited efficacy and unsatisfactory response rates. Progress in developing effective therapies is hampered by the insufficiently understood heterogeneity of MDD and its elusive underlying mechanisms. Here, to address these challenges, we develop a novel machine learning framework that identifies structure–function covariation through target-oriented fusion of structural and functional connectivity, which robustly predicts individual-level antidepressant response (sertraline, R2 = 0.31; placebo, R2 = 0.22). Validation in an independent escitalopram-medicated MDD cohort confirms the biomarker’s generalizability (P = 0.01) and suggests an overlap of psychopharmacological signatures across selective serotonin reuptake inhibitors. Our models highlight the right precuneus as a common key region for both sertraline and placebo responses, with the right middle frontal gyrus and left fusiform gyrus specific to sertraline and the left inferior and middle frontal gyri to placebo. We also find that structural connectivity is more predictive of sertraline response, while functional connectivity better predicts placebo response. The framework further decomposes the overall predictive patterns into three constitutive network constellations (default-mode regulatory, affective and sensory processing), which exhibit distinct generalizable structure–function covariation and treatment-specific association with personality traits and behavioral/cognitive profiles. These findings provide unique insights to the structure–function covariation in patients with MDD, its association to the heterogeneity in antidepressant response and the dissection of the intricate MDD neuropsychopharmacology, paving the way for precision medicine and development of more targeted antidepressant therapeutics. Clinicaltrials.gov registration: Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression (EMBARC), NCT01407094.
- Open Access
- 18 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Electroconvulsive therapy generates a postictal wave of spreading depolarization in mice and humans
Electroconvulsive therapy (ECT) is a fast-acting, highly effective, and safe treatment for medication-resistant depression. Historically, the clinical benefits of ECT have been attributed to generating a controlled seizure; however, the underlying neurobiology is understudied and unresolved. Using optical neuroimaging of neural activity and hemodynamics in a mouse model of ECT, we demonstrated that a second brain event follows seizure: cortical spreading depolarization (CSD). We found that ECT pulse parameters and electrode configuration directly shaped the wave dynamics of seizure and subsequent CSD. To translate these findings to human patients, we used non-invasive diffuse optical monitoring of cerebral blood flow and oxygenation during routine ECT treatments. We observed that human brains reliably generate hyperemic waves after ECT seizure which are highly consistent with CSD. These results challenge a long-held assumption that seizure is the primary outcome of ECT and point to new opportunities for optimizing ECT stimulation parameters and treatment outcomes.
- 18 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessElectroconvulsive therapy generates a postictal wave of spreading depolarization in mice and humans
Electroconvulsive therapy (ECT) is a fast-acting, highly effective, and safe treatment for medication-resistant depression. Historically, the clinical benefits of ECT have been attributed to generating a controlled seizure; however, the underlying neurobiology is understudied and unresolved. Using optical neuroimaging of neural activity and hemodynamics in a mouse model of ECT, we demonstrated that a second brain event follows seizure: cortical spreading depolarization (CSD). We found that ECT pulse parameters and electrode configuration directly shaped the wave dynamics of seizure and subsequent CSD. To translate these findings to human patients, we used non-invasive diffuse optical monitoring of cerebral blood flow and oxygenation during routine ECT treatments. We observed that human brains reliably generate hyperemic waves after ECT seizure which are highly consistent with CSD. These results challenge a long-held assumption that seizure is the primary outcome of ECT and point to new opportunities for optimizing ECT stimulation parameters and treatment outcomes.
- Open Access
- 11 March 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (8) , 3579-3587
Neuroimaging changes in major depression with brief computer-assisted cognitive behavioral therapy compared to waitlist
The goals of the current study were to determine the efficacy in major depressive disorder (MDD) of a shortened, computer-augmented cognitive behavioral therapy (CCBT) protocol and to determine brain plasticity effects following CCBT. Seventy-two MDD participants were randomized to CCBT or waitlist control groups and compared to 40 healthy controls (HCs). Functional MRI data were collected for all participants and repeated for patients following CCBT (five therapist-administered manualized CBT sessions plus computer training exercises). Linear mixed-effects models evaluated changes in depression scores throughout treatment and in connectivity from pre- to post-CCBT. Linear regression models compared connectivity differences between groups (MDD vs. HC). Following CCBT, there were decreases in MADRS and BDI (ps < 0.001); there was more negative connectivity of dlPFC with sgACC and DMN with sgACC (ps < 0.002); and there was more positive connectivity of FPN with nucleus accumbens, bilateral amygdalae, bilateral hippocampi, and sgACC and of DMN with ventral and dorsal bilateral anterior insulae (ps < 0.01). There were no associations between change in MADRS and change in connectivity; however, there was an association between change in BDI and change in FPN–sgACC connectivity (p = 0.01). A shortened CBT schedule coupled with home computer exercises was associated with decreased depression symptoms and augmented PFC connectivity with multiple subcortical regions. One possible mechanism of the CCBT intervention is modulating PFC connectivity with subcortical regions, influencing top-down control of affective processes dysregulated in MDD.
- 11 March 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (8) , 3579-3587
Open AccessNeuroimaging changes in major depression with brief computer-assisted cognitive behavioral therapy compared to waitlist
The goals of the current study were to determine the efficacy in major depressive disorder (MDD) of a shortened, computer-augmented cognitive behavioral therapy (CCBT) protocol and to determine brain plasticity effects following CCBT. Seventy-two MDD participants were randomized to CCBT or waitlist control groups and compared to 40 healthy controls (HCs). Functional MRI data were collected for all participants and repeated for patients following CCBT (five therapist-administered manualized CBT sessions plus computer training exercises). Linear mixed-effects models evaluated changes in depression scores throughout treatment and in connectivity from pre- to post-CCBT. Linear regression models compared connectivity differences between groups (MDD vs. HC). Following CCBT, there were decreases in MADRS and BDI (ps < 0.001); there was more negative connectivity of dlPFC with sgACC and DMN with sgACC (ps < 0.002); and there was more positive connectivity of FPN with nucleus accumbens, bilateral amygdalae, bilateral hippocampi, and sgACC and of DMN with ventral and dorsal bilateral anterior insulae (ps < 0.01). There were no associations between change in MADRS and change in connectivity; however, there was an association between change in BDI and change in FPN–sgACC connectivity (p = 0.01). A shortened CBT schedule coupled with home computer exercises was associated with decreased depression symptoms and augmented PFC connectivity with multiple subcortical regions. One possible mechanism of the CCBT intervention is modulating PFC connectivity with subcortical regions, influencing top-down control of affective processes dysregulated in MDD.